Telomerase Deletion Limits Progression of p53-Mutant Hepatocellular Carcinoma With Short Telomeres in Chronic Liver Disease

Gastroenterology

Volumn 132, Issue 4, 2007, Pages 1465-1475

  Lechel, André ^a   Holstege, Henne ^b   Begus, Yvonne ^a   Schienke, Andrea ^a   Kamino, Kenji ^a   Lehmann, Ulrich ^a   Kubicka, Stefan ^a   Schirmacher, Peter ^c   Jonkers, Jos ^b   Rudolph, K Lenhard ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MUTANT PROTEIN; PROTEIN P53; TELOMERASE;

ANEUPLOIDY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER STAGING; CELL PROLIFERATION; CHRONIC LIVER DISEASE; COHORT ANALYSIS; GENE DELETION; GENE EXPRESSION; IN VIVO STUDY; KNOCKOUT MOUSE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER INJURY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TELOMERE; TUMOR CELL;

EID: 34247268524     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2007.01.045     Document Type: Article

References (39)

1. Lotze M.T., Flickinger J.C., and Carr B.I. Hepatobiliary neoplasm. In: DeVita V.T., Hellmann S., and Rosenberg S.A. (Eds). Cancer: principles and practice of oncology. 4th ed (1993), Lippincott, Philadelphia, PA 883-887
2. Ohashi K., Tsutsumi M., Nakajima Y., Kobitsu K., Nakano H., and Konishi Y. Telomere changes in human hepatocellular carcinomas and hepatitis virus infected noncancerous livers. Cancer 77 (1996) 1747-1751
3. Plentz R.R., Caselitz M., Bleck J.S., Gebel M., Flemming P., Kubicka S., Manns M.P., and Rudolph K.L. Hepatocellular telomere shortening correlates with chromosomal instability and the development of human hepatocellular carcinoma. Hepatology 40 (2004) 80-86
4. Plentz R.R., Schlegelberger B., Flemming P., Manns M.P., Rudolph K.L., and Wilkens L. Telomere shortening correlates with increasing aneuploidy of chromosome 8 on a cellular level in primary human hepatocellular carcinoma. Hepatology 42 (2005) 522-526
5. Thorgeirsson S.S., and Grisham J.W. Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet 31 (2002) 339-346
6. Tannapfel A., Busse C., Weinans L., Benicke M., Katalinic A., Geissler F., Hauss J., and Wittekind C. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas. Oncogene 20 (2001) 7104-7109
7. Nishida N., Nishimura T., Ito T., Komeda T., Fukuda Y., and Nakao K. Chromosomal instability and human hepatocarcinogenesis. Histol Histopathol 18 (2003) 897-909
8. Hashimoto K., Mori N., Tamesa T., Okada T., Kawauchi S., Oga A., Furuya T., Tangoku A., Oka M., and Sasaki K. Analysis of DNA copy number aberrations in hepatitis C virus-associated hepatocellular carcinomas by conventional CGH and array CGH. Mod Pathol 17 (2004) 617-622
9. Wilkens L., Flemming P., Gebel M., Bleck J., Terkamp C., Wingen L., Kreipe H., and Schlegelberger B. Induction of aneuploidy by increasing chromosomal instability during dedifferentiation of hepatocellular carcinoma. Proc Natl Acad Sci U S A 101 (2004) 1309-1314
10. Greenberg R.A., Chin L., Femino A., Lee K.H., Gottlieb G.J., Singer R.H., Greider C.W., and DePinho R.A. Short dysfunctional telomeres impair tumorigenesis in the INK4a(delta2/3) cancer-prone mouse. Cell 97 (1999) 515-525
11. Gonzalez-Suarez E., Samper E., Flores J.M., and Blasco M.A. Telomerase-deficient mice with short telomeres are resistant to skin tumorigenesis. Nat Genet 26 (2000) 114-117
12. Rudolph K.L., Millard M., Bosenberg M.W., and DePinho R.A. Telomere dysfunction and evolution of intestinal carcinoma in mice and humans. Nat Genet 28 (2001) 155-159
13. Farazi P.A., Glickmann J., Jiang S., Yu A., Rudolph K.L., and DePinho R.A. Differential impact of telomere dysfunction on initiation and progression of hepatocellular carcinoma. Cancer Res 63 (2003) 5021-5027
14. Chang S., Khoo C.M., Naylor M.L., Maser R.S., and DePinho R.A. Telomere-based crisis: functional differences between telomerase activation and ALT in tumor progression. Genes Dev 17 (2003) 88-100
15. Rudolph K.L., Chang S., Lee H.W., Blasco M., Gottlieb G.J., Greider C., and DePinho R.A. Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell 96 (1999) 701-712
16. Artandi S.E., Chang S., Lee S.L., Alson S., Gottlieb G.J., Chin L., and DePinho R.A. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature 406 (2000) 641-645
17. Chin L., Artandi S.E., Shen Q., Tam A., Lee S.L., Gottlieb G.J., Greider C.W., and DePinho R.A. p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell 97 (1999) 527-538
18. Farazi P.A., Glickman J., Horner J., and DePinho R.A. Cooperative interactions of p53 mutation, telomere dysfunction and chronic liver damage in hepatocellular carcinoma progression. Cancer Res 66 (2006) 4766-4773
19. Miura N., Horikawa I., Nishimoto A., Ohmura H., Ito H., Hirohashi S., Shay J.W., and Oshimura M. Progressive telomere shortening and telomerase reactivation during hepatocellular carcinogenesis. Cancer Genet Cytogenet 93 (1997) 56-62
20. Takahashi S., Kitamoto M., Takaishi H., Aikata H., Kawakami Y., Nakanishi T., Shimamoto F., Tahara E., Tahara H., Ide T., and Kajiyama G. Expression of telomerase component genes in hepatocellular carcinomas. Eur J Cancer 36 (2000) 496-502
21. Wright W.E., and Shay J.W. The two-stage mechanism controlling cellular senescence and immortalization. Exp Gerontol 27 (1992) 383-389
22. Counter C.M., Avilion A.A., LeFeuvre C.E., Stewart N.G., Greider C.W., Harley C.B., and Bacchetti S. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 11 (1992) 1921-1929
23. d'Adda di Fagagna F., Reaper P.M., Clay-Farrace L., Fiegler H., Carr P., Von Zglinicki T., Saretzki G., Carter N.P., and Jackson S.P. A DNA damage checkpoint response in telomere-initiated senescence. Nature 426 (2003) 194-198
24. Bond J.A., Wyllie F.S., and Wynford-Thomas D. Escape from senescence in human diploid fibroblasts induced directly by mutant p53. Oncogene 9 (1994) 1885-1889
25. Jonkers J., Meuwissen R., van der Gulden H., Peterse H., van der Valk M., and Berns A. Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer. Nat Genet 29 (2001) 418-425
26. Blasco M.A., Lee H.W., Hande M.P., Samper E., Lansdorp P.M., DePinho R.A., and Greider C.W. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91 (1997) 25-34
27. Chisari F.V., Klopchin K., Moriyama T., Pasquinelli C., Dunsford H.A., Sell S., Pinkert C.A., Brinster R.L., and Palmiter R.D. Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice. Cell 59 (1989) 1145-1156
28. Hemann M.T., Strong M.A., Hao L.Y., and Greider C.W. The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability. Cell 107 (2001) 67-77
29. Akagi K., Sandig V., Vooijs M., Van der Valk M., Giovannini M., Strauss M., and Berns A. Cre-mediated somatic site-specific recombination in mice. Nucleic Acids Res 25 (1997) 1766-1773
30. Kim N.W., and Wu F. Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP). Nucleic Acids Res 25 (1997) 2595-2597
31. Poon S.S., Martens U.M., Ward R.K., and Lansdorp P.M. Telomere length measurements using digital fluorescence microscopy. Cytometry 36 (1999) 267-278
32. Chung Y.J., Jonkers J., Kitson H., Fiegler H., Humphray S., Scott C., Hunt S., Yu Y., Nishijima I., Velds A., Holstege H., Carter N., and Bradley A. A whole-genome mouse BAC microarray with 1-Mb resolution for analysis of DNA copy number changes by array comparative genomic hybridization. Genome Res 14 (2004) 188-196
33. Hughes T.R., Marton M.J., Jones A.R., Roberts C.J., Stoughton R., Armour C.D., Bennett H.A., Coffey E., Dai H., He Y.D., Kidd M.J., King A.M., Meyer M.R., Slade D., Lum P.Y., Stepaniants S.B., Shoemaker D.D., Gachotte D., Chakraburtty K., Simon J., Bard M., and Friend S.H. Functional discovery via a compendium of expression profiles. Cell 102 (2000) 109-126
34. Llovet J.M., Burroughs A., and Bruix J. Hepatocellular carcinoma. Lancet 362 (2003) 1907-1917
35. Wiemann S.U., Satyanarayana A., Buer J., Kamino K., Manns M.P., and Rudolph K.L. Contrasting effects of telomere shortening on organ homeostasis, tumor suppression, and survival during chronic liver damage. Oncogene 24 (2005) 1501-1509
36. Frith C.H., Wards J.M., and Turusoz V.S. Tumours of the liver. In: Tursov V., and Mohr U. (Eds). Pathology of tumours in laboratory animals, Vol. 2-tumours of the mouse (1994), IARC, Lyon, France 223-243
37. Moinzadeh P., Breuhahn K., Stutzer H., and Schirmacher P. Chromosome alterations in human hepatocellular carcinomas correlate with aetiology and histological grade--results of an explorative CGH meta-analysis. Br J Cancer 92 (2005) 935-941
38. Zhu J., Wang H., Bishop J.M., and Blackburn E.H. Telomerase extends the lifespan of virus-transformed human cells without net telomere lengthening. Proc Natl Acad Sci U S A 96 (1999) 3723-3728
39. Lechel A., Satyanarayana A., Ju Z., Plentz R.R., Schaetzlein S., Rudolph C., Wilkens L., Wiemann S.U., Saretzki G., Malek N.P., Manns M.P., Buer J., and Rudolph K.L. The cellular level of telomere dysfunction determines induction of senescence or apoptosis in vivo. EMBO Rep 6 (2005) 275-281